Supernus Pharmaceuticals, Inc. (SUPN) NASDAQ
44.07
-0.69(-1.54%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.81B |
| Enterprise Value | 2.72B |
| P/E Ratio | -87.56 |
| PEG Ratio | 0.9 |
| Price/Sales Ratio | 3.29 |
| Price/Book Ratio | 2.36 |
| Enterprise/Revenue | 3.11 |
| Enterprise/EBITDA | 55.56 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.04 |
| Operating Margin | -0.05 |
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 718.95M |
| Revenue/Share | 13.48 |
| Gross Profit | 644.39M |
| EBITDA | 42.53M |
| Net Income | -38.55M |
| Diluted EPS | -0.68 |
Balance Sheet
| Total Cash | 384.24M |
| Total Cash/Share | 6.67 |
| Total Debt | 40.9M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 1.96 |
| Book Value Per Share | 18.68 |
Price History
| 52-Week Change | 38.11 |
| 52-Week High | 59.68 |
| 52-Week Low | 30.83 |
| Moving Average 50 Days | 49.57 |
| Moving Average 200 Days | 48.95 |
Statistics
| Average Volume | 642,334 |
| Shares Outstanding | 58.04M |
| % Held by Institutions | 103.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
